FDA allowed both qualified and unqualified entities to flood the market with COVID-19 antibody tests, and the result was “chaos,” FDA’s former chief scientist Jesse Goodman told a U.S. House subcommittee.
A month after FDA tightened oversight of the tests and started withdrawing tests from the market, there is still enough concern about false results that the American Medical Association is recommending against people using the tests outside of certain settings, added Dr. Jesse Ehrenfeld, immediate past chair of the AMA’s board of trustees, speaking yesterday to the Subcommittee on Economic and Consumer Policy.
Get the full story on our sister site Medical Design & Outsourcing.
